A role for endogenous retroelements in Aicardi-Goutieres Syndrome
内源性逆转录因子在 Aicardi-Goutieres 综合征中的作用
基本信息
- 批准号:9296176
- 负责人:
- 金额:$ 20.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-06-14 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:17 year oldADAR1AddressAffectAlgorithmic AnalysisAmyotrophic Lateral SclerosisAntigensAutoantibodiesAutoimmune ProcessAwarenessBasal GangliaBioinformaticsBiological AssayBloodBrainCalciumCause of DeathCell LineCellsCerebrospinal FluidCessation of lifeChildhoodComplementary DNACrowsDNADNA Sequencing FacilityDataDepositionDiseaseDisease ProgressionElectronic MailElementsEmbryonic DevelopmentEncephalopathiesEndogenous RetrovirusesEnzyme-Linked Immunosorbent AssayFish ProteinsFutureGene ProteinsGenesGenetic TranscriptionGenomeGenomicsGrantHigh-Throughput Nucleotide SequencingHumanHuman GenomeImmune responseImmune systemImmunologyImpairmentIndividualInfectionInflammatoryInnate Immune SystemInsertion MutationInterferon Type IInterferonsInvestigationLaboratoriesLaboratory StudyLeukocytesLifeLightLinkMalignant NeoplasmsMentorsMetabolismMolecular ProfilingMultiple SclerosisMusMutationNervous System TraumaNeuraxisNeuronsNucleic AcidsPaste substancePathologyPatientsPhenotypePostdoctoral FellowProcessProtein AnalysisProteinsProtocols documentationPseudogenesRNARNA analysisRNA-Directed DNA PolymeraseRecruitment ActivityRelaxationResearchResearch PersonnelRetroelementsRetrotranspositionRetrotransposonRetroviridaeReverse TranscriptionRheumatismRoleSamplingSerumSeveritiesSignal TransductionSkinSomatic CellSourceSystemic Lupus ErythematosusTREX1 geneTeleconferencesTestingTissuesTransgenesVariantWorkbasebrain dysfunctionbrain tissuecell typecohortearly childhoodearly onsetexperiencefunctional losshuman DNAimmunocytochemistryin vivoinsightinterestleukodystrophymouse modelnext generation sequencingnovelperipheral bloodprotein expressionpseudotoxoplasmosis syndromepublic health relevanceresponseskin lesionsystemic autoimmune diseasetranscriptome sequencingtransposon/insertion elementtreatment strategy
项目摘要
DESCRIPTION (provided by applicant): A role for endogenous retroelements in Aicardi-Goutières syndrome Aicardi-Goutières syndrome (AGS) is a severe Mendelian inflammatory disorder that affects particularly the brain and frequently causes death in childhood. The disease is characterized by progressive encephalopathy, psychomotor regression, and lesions of the skin, together with increased levels of Type I interferon in the cerebrospinal fluid and serum, and
induction of interferon-stimulated genes detectable in peripheral blood. Causative mutations have been identified in seven genes, TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1 and IFIH1, with variation in the severity of their associated phenotypes. The protein products of these genes are involved in RNA metabolism or signaling, and have also been linked with suppression of infecting retroviruses and/or endogenous retrotransposons. This study is based on the hypothesis that functional loss of an AGS-associated gene alters the normal metabolism of retrotransposon RNA or its reverse-transcribed cDNA, triggering an interferon response and AGS. Retrotransposons are mobile DNA elements that duplicate themselves by a "copy and paste" mechanism using an RNA intermediate. Endogenous retroviruses (HERVs) comprise 8% of the human genome. Although no HERVs capable of replication have been identified, ongoing HERV expression has been implicated in several disease conditions, including multiple sclerosis, amyotrophic lateral sclerosis, and autoimmune rheumatic disease. LINE1 (L1) retrotransposons occupy 17% of human DNA, although it is believed that only about 100 remain competent for retrotransposition in any individual. L1 retrotransposition has also been responsible for the insertion of over a million non-autonomous Alu retrotransposons and thousands of processed pseudogenes. The cell has evolved defenses restricting retrotransposition, which are occasionally relaxed in certain somatic cell types, notably neuronal cells in the human brain. We predict relaxation of retroelement expression in AGS patients. Using RNA analyses, immunocytochemistry, and functional assays for reverse transcriptase activity, we will examine brain tissue, blood, sera, and derived cell lines from AGS patients to ascertain if retroelement RNA or protein expression is elevated in the disease state. We will determine if de novo L1 and Alu insertion numbers are increased in tissues of AGS patients using high-throughput sequencing protocols. The question of whether L1 expression can induce an interferon response will be addressed using a mouse model harboring an inducible L1 transgene. Finally, we will develop ELISA assays to ascertain if sera from AGS patients contain autoantibodies directed against retroelement proteins. This research should shed new light on a devastating childhood disease and suggest future strategies for treatment. Furthermore, new insights into the interaction of the intrinsic immune system of the cell and endogenous retroelements will be gained.
描述(由申请人提供):内源性逆转录因子在 Aicardi-Goutières 综合征中的作用 Aicardi-Goutières 综合征 (AGS) 是一种严重的孟德尔炎症性疾病,特别影响大脑并经常导致儿童死亡。该疾病的特征是进行性脑病,精神运动退化和皮肤损伤,以及脑脊液和血清中 I 型干扰素水平升高,以及
外周血中可检测到的干扰素刺激基因的诱导已在七个基因中发现,即 TREX1、RNASEH2A、RNASEH2B、RNASEH2C、SAMHD1、ADAR1 和 IFIH1,其相关表型的严重程度存在差异。参与 RNA 代谢或信号传导,并且还与感染逆转录病毒和/或内源逆转录转座子的抑制有关。假设 AGS 相关基因的功能丧失会改变逆转录转座子 RNA 或其逆转录 cDNA 的正常代谢,从而引发干扰素反应,而逆转录转座子是可移动的 DNA 元件,可使用 RNA 通过“复制和粘贴”机制进行自我复制。内源性逆转录病毒 (HERV) 占人类基因组的 8%,尽管尚未发现能够复制的 HERV,但持续的 HERV 表达与多种疾病有关,包括多种疾病。硬化症、肌萎缩性脊髓侧索硬化症和自身免疫性风湿病的 LINE1 (L1) 逆转录转座子占据了人类 DNA 的 17%,尽管据信在任何个体中只有大约 100 个具有逆转录转座能力,这也是导致过度插入的原因。一百万个非自主 Alu 逆转录转座子和数千个经过加工的假基因细胞已经进化出限制逆转录转座的防御,这些防御有时会在某些情况下放松。我们将使用 RNA 分析、免疫细胞化学和逆转录酶活性功能分析来预测 AGS 患者的体细胞类型,特别是人脑中的神经细胞。我们将使用高通量测序方案确定 AGS 患者组织中的 de novo L1 和 Alu 插入数量是否增加。 L1 表达是否可以诱导干扰素反应的问题将使用含有诱导型 L1 转基因的小鼠模型来解决。最后,我们将开发 ELISA 测定法来确定 AGS 患者的血清是否含有针对逆转录因子蛋白的自身抗体。此外,还将获得关于细胞内在免疫系统和内源性逆转录因子相互作用的新见解。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Aicardi-Goutières syndrome protein TREX1 suppresses L1 and maintains genome integrity through exonuclease-independent ORF1p depletion.
Aicardi-Goutieres 综合征蛋白 TREX1 通过不依赖外切核酸酶的 ORF1p 耗竭抑制 L1 并维持基因组完整性
- DOI:10.1093/nar/gkx178
- 发表时间:2017-05-05
- 期刊:
- 影响因子:14.9
- 作者:Li P;Du J;Goodier JL;Hou J;Kang J;Kazazian HH Jr;Zhao K;Yu XF
- 通讯作者:Yu XF
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN Lawrence GOODIER其他文献
JOHN Lawrence GOODIER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN Lawrence GOODIER', 18)}}的其他基金
Retrotransposition independent LINE 1-induced DNA damage in normal and aging cells
正常细胞和衰老细胞中不依赖逆转录转座的 LINE 1 诱导的 DNA 损伤
- 批准号:
9766167 - 财政年份:2018
- 资助金额:
$ 20.43万 - 项目类别:
Exploring a role for LINE1 retrotransposons in neurodegenerative disease
探索 LINE1 逆转录转座子在神经退行性疾病中的作用
- 批准号:
8678465 - 财政年份:2014
- 资助金额:
$ 20.43万 - 项目类别:
Exploring a role for LINE1 retrotransposons in neurodegenerative disease
探索 LINE1 逆转录转座子在神经退行性疾病中的作用
- 批准号:
8805859 - 财政年份:2014
- 资助金额:
$ 20.43万 - 项目类别:
Retrotransposons as site-specific gene delivery vectors
逆转录转座子作为位点特异性基因递送载体
- 批准号:
6466397 - 财政年份:2002
- 资助金额:
$ 20.43万 - 项目类别:
Retrotransposons as site-specific gene delivery vectors
逆转录转座子作为位点特异性基因递送载体
- 批准号:
6623503 - 财政年份:2002
- 资助金额:
$ 20.43万 - 项目类别:
相似国自然基金
METTL3介导m6A甲基化ADAR1下调cGAS-STING通路改善衰老相关认知功能障碍
- 批准号:82360230
- 批准年份:2023
- 资助金额:32.2 万元
- 项目类别:地区科学基金项目
诱导型ADAR1持续启动滞育样重编程介导舌鳞癌细胞休眠的机制研究
- 批准号:82303468
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向RNA腺苷脱氨酶(ADAR1)的抑制剂发现与抗肿瘤活性研究
- 批准号:82304379
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ADAR1通过编辑p120调控F-actin-YAP/TAZ机械转导通路促进非小细胞肺癌生长和转移的机制研究
- 批准号:82303488
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肿瘤相关巨噬细胞诱发ADAR1介导的A-to-I编辑调控pri-miRNA的成熟在骨肉瘤侵袭转移中的作用及机制研究
- 批准号:82373051
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Developing computational methods to identify of endogenous substrates of E3 ubiquitin ligases and molecular glue degraders
开发计算方法来鉴定 E3 泛素连接酶和分子胶降解剂的内源底物
- 批准号:
10678199 - 财政年份:2023
- 资助金额:
$ 20.43万 - 项目类别:
ADAR mediated RNA editing is a causal mechanism in coronary artery disease
ADAR 介导的 RNA 编辑是冠状动脉疾病的因果机制
- 批准号:
10629687 - 财政年份:2023
- 资助金额:
$ 20.43万 - 项目类别:
Elucidating the mechanism by which ADAR1 prevents autoimmunity against self RNA
阐明 ADAR1 预防针对自身 RNA 的自身免疫的机制
- 批准号:
10667182 - 财政年份:2023
- 资助金额:
$ 20.43万 - 项目类别:
Molecular recognition by ADAR1 of Z-RNA within transcriptomes
ADAR1 对转录组中 Z-RNA 的分子识别
- 批准号:
10712207 - 财政年份:2023
- 资助金额:
$ 20.43万 - 项目类别:
Regulatory and Mechanistic Understanding of ADAR-Mediated RNA Editing
ADAR 介导的 RNA 编辑的监管和机制理解
- 批准号:
10630935 - 财政年份:2022
- 资助金额:
$ 20.43万 - 项目类别: